当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析

以岭药业

(002603)

  

流通市值:208.41亿  总市值:252.94亿
流通股本:13.77亿   总股本:16.71亿

以岭药业(002603)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润4.09亿元,每股收益0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1139089.22万元,未分配利润647447.50万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1417793.15万元,负债278703.93万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,439,783,832.767,830,737,438.745,867,603,073.614,040,142,217.94
营业总成本1,941,982,482.086,149,554,601.934,704,006,732.643,245,278,851.39
其他经营收益
营业利润499,741,266.751,623,431,472.751,187,306,072.6821,536,367.61
利润总额489,099,279.31,591,610,902.081,169,635,400.22803,653,759.54
净利润408,612,429.21,281,729,907.88996,674,335.9665,298,290.44
每股收益
其他综合收益382,786.36-713,93896,367.62-115,833.71
综合收益总额408,995,215.561,281,015,969.88996,770,703.52665,182,456.73
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计5,785,791,884.735,206,141,683.315,539,592,346.045,167,877,833.07
非流动资产:
非流动资产合计8,392,139,621.58,468,856,813.648,680,716,780.668,731,435,279.68
资产总计14,177,931,506.2313,674,998,496.9514,220,309,126.713,899,313,112.75
流动负债:
流动负债合计2,312,447,975.12,208,205,004.613,000,577,881.412,526,367,038.15
非流动负债:
非流动负债合计474,591,292.78484,896,469.55522,079,488.86505,670,952.16
负债合计2,787,039,267.882,693,101,474.163,522,657,370.273,032,037,990.31
所有者权益(或股东权益):
归属于母公司股东权益合计11,398,333,808.0110,989,102,712.0810,703,839,026.9310,872,968,791.22
股东权益合计11,390,892,238.3510,981,897,022.7910,697,651,756.4310,867,275,122.44
负债和股东权益合计14,177,931,506.2313,674,998,496.9514,220,309,126.713,899,313,112.75
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,526,488,972.528,795,003,112.746,391,353,472.814,302,887,897.64
经营活动现金流出小计1,915,779,157.997,018,494,734.275,113,114,503.773,470,847,821.68
经营活动产生的现金流量净额610,709,814.531,776,508,378.471,278,238,969.04832,040,075.96
投资活动产生的现金流量:
投资活动现金流入小计814,679,962.91,497,642,892.99894,514,968.75794,200,757.18
投资活动现金流出小计1,744,183,825.32,499,617,151.141,975,541,905.951,441,157,764.76
投资活动产生的现金流量净额-929,503,862.4-1,001,974,258.15-1,081,026,937.2-646,957,007.58
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计2,320,329.25513,633,146.957,307,247.285,423,118.14
筹资活动产生的现金流量净额-2,320,329.25-513,633,146.95-7,307,247.28-5,423,118.14
汇率变动对现金及现金等价物的影响274,475.71-812,591.14234,642.31143,861.51
现金及现金等价物净增加额-320,839,901.41260,088,382.23190,139,426.87179,803,811.75
期末现金及现金等价物余额755,851,655.221,076,691,556.631,006,742,601.27996,406,986.15
补充资料:
现金及现金等价物的净增加额-260,088,382.23-179,803,811.75
最新报告期:2026-05-22
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信建投袁全,刘若飞,沈兴熙,贺菊颖0.911.061.222026-05-22
中信建投袁全,刘若飞,沈兴熙,贺菊颖0.911.061.222026-05-20
华创证券郑辰,高初蕾0.921.061.212026-05-14
国泰海通张澄,彭娉,郑琴0.921.061.202026-05-02
华泰证券代雯,唐庆雷,张云逸0.921.091.262026-04-29
TOP↑